<bill session="114" type="h" number="5127" updated="2018-11-21T21:23:35Z">
  <state datetime="2016-04-29">REFERRED</state>
  <status>
    <introduced datetime="2016-04-29"/>
  </status>
  <introduced datetime="2016-04-29"/>
  <titles>
    <title type="short" as="introduced">Curb Opioid Misuse By Advancing Technology Act of 2016</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to extend the exclusivity period for certain drug products developed or labeled so as to reduce drug abuse, and for other purposes.</title>
    <title type="display">Curb Opioid Misuse By Advancing Technology Act of 2016</title>
  </titles>
  <sponsor bioguide_id="G000568"/>
  <cosponsors>
    <cosponsor bioguide_id="B001257" joined="2016-04-29"/>
    <cosponsor bioguide_id="B001243" joined="2016-11-14"/>
    <cosponsor bioguide_id="B001296" joined="2016-06-28"/>
    <cosponsor bioguide_id="C001092" joined="2016-06-15"/>
    <cosponsor bioguide_id="C001078" joined="2016-04-29"/>
    <cosponsor bioguide_id="D000613" joined="2016-09-08"/>
    <cosponsor bioguide_id="F000451" joined="2016-07-07"/>
    <cosponsor bioguide_id="S001192" joined="2016-09-19"/>
    <cosponsor bioguide_id="V000131" joined="2016-09-08"/>
    <cosponsor bioguide_id="W000808" joined="2016-11-14"/>
  </cosponsors>
  <actions>
    <action datetime="2016-04-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-04-29" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2016-05-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Medical research"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-29T04:00:00Z" status="Introduced in House">Curb Opioid Misuse By Advancing Technology Act of 2016

This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities.

The bill also extends the marketing exclusivity period for generics of these drugs.</summary>
  <committee-reports/>
</bill>
